Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
Objective The coronavirus disease 2019 (COVID-19) pandemic has reduced the demand for, and supply of, head and neck cancer services. This study compares the times to diagnosis, staging, and treatment of head and neck cancers before and during the COVID-19 pandemic. Study Design Retrospective cohort...
Guardado en:
Autores principales: | Peter Yao, Victoria Cooley MS, William Kuhel MD, Andrew Tassler MD, Victoria Banuchi MD, Sallie Long MD, Oleksandr Savenkov PhD, David Ivan Kutler MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9c3cc9770f14dfcac1571ce8e716c28 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel therapeutics and emerging technologies in head and neck cancer
por: Theodoros N. Teknos, M.D.
Publicado: (2016) -
Tumor-Associated Macrophages in Vestibular Schwannoma and Relationship to Hearing
por: Eric Nisenbaum MD, et al.
Publicado: (2021) -
Value within otolaryngology: Assessment of the cost-utility analysis literature
por: Krupa R. Patel, et al.
Publicado: (2016) -
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review 2020
por: Michael J. Brenner MD, et al.
Publicado: (2021) -
Novel p53 therapies for head and neck cancer
por: Mario R. Castellanos, et al.
Publicado: (2016)